News

News flash: ORIL’s CEO has great news to share with Shareholders.

Nov 05th, 2013

The company has some great news regarding a major financial commitment it has recently received from a sophisticated investor. This and other news are discussed in the CEO’s letter to Shareholders which can be downloaded from our Company reports section.

Quarterly Update 3Q 2013 now available

Oct 11th, 2013

The CEO Update for the third quarter of 2013 is now available from our Company reports section.

2013 financial results now available.

Oct 10th, 2013

The company’s financial results for 2013 are now available from our Company reports section.

News

> Letter to Shareholders re CEO
> Interim Financial Report – Half-Year Ended 31 Dec 2021
> Michael Wayte notice
> 2021 Financial Statements

Address

Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia

Links